Back to MW MARSHALL WACE, LLP
OKUR2 quarters
Position history for MWMARSHALL WACE, LLP's holdings in ONKURE THERAPEUTICS INC
Yes. Marshall Wace holds 159,881 shares of OKUR (Onkure Therapeutics), worth $729,057, as of its Q2 2026 13F filing. It increased the position from 36,444 shares in Q1 2026. Marshall Wace has held OKUR since Q1 2026, across 2 quarterly 13F filings.
Current Value
$729,057
Current Shares
159,881
Total Value Change
+$578,179
Total Shares Change
+123,437
Quarter-by-Quarter History
Other major holders of OKUR: RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC